News Release
First quarter 2024 net income (loss) was
First Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations for Aluminum Extrusions was
$12.5 million in the first quarter of 2024 versus$14.6 million in the first quarter of last year and$8.0 million in the fourth quarter of 2023.- Sales volume was 33.8 million pounds in the first quarter of 2024 versus 37.6 million pounds in the first quarter of last year and 32.9 million pounds in the fourth quarter of 2023.
- Open orders at the end of the first quarter of 2024 were approximately 15 million pounds (versus 27 million pounds in the first quarter of 2023 and 14 million pounds at the end of the fourth quarter of 2023). Net new orders increased 61% and 12% in the first quarter of 2024 versus the first quarter of 2023 and fourth quarter of 2023, respectively.
-
EBITDA from ongoing operations for
PE Films was$6.9 million in the first quarter of 2024 versus$1.8 million in the first quarter of 2023 and$4.5 million in the fourth quarter of 2023. Sales volume was 10.0 million pounds in the first quarter of 2024 versus 7.4 million pounds in the first quarter of 2023 and 8.5 million pounds in the fourth quarter of 2023. -
EBITDA from ongoing operations for
Flexible Packaging Films (also referred to as "Terphane") was$2.0 million during the first quarter of 2024 versus$1.4 million in the first quarter of 2023 and$2.3 million during the fourth quarter of 2023. Sales volume was 22.0 million pounds in the first quarter of 2024 versus 19.8 million pounds in the first quarter 2023 and 22.8 million pounds in the fourth quarter of 2023. See the Status of Agreement to Sell Terphane section of this report for information on the sale of Terphane.
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions (or
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||
(In thousands, except percentages) |
|
|
|||||||
2024 |
|
2023 |
|
||||||
Sales volume (lbs) |
|
33,841 |
|
|
|
37,562 |
|
|
(9.9)% |
Net sales |
$ |
114,222 |
|
|
$ |
133,370 |
|
|
(14.4)% |
Ongoing operations: |
|
|
|
|
|
||||
EBITDA |
$ |
12,540 |
|
|
$ |
14,638 |
|
|
(14.3)% |
Depreciation & amortization |
|
(4,542 |
) |
|
|
(4,411 |
) |
|
(3.0)% |
EBIT* |
$ |
7,998 |
|
|
$ |
10,227 |
|
|
(21.8)% |
Capital expenditures |
$ |
1,550 |
|
|
$ |
7,742 |
|
|
|
* For a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP, see the EBITDA from ongoing operations by segment statements in the Financial Tables in this press release. |
The following table presents the sales volume by end use market for the three months ended
|
|
Three Months Ended |
|
Favorable/ |
|
Three Months Ended |
|
Favorable/ |
||||
(In millions of lbs) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||
|
2024 |
|
2023 |
|
% Change |
|
2023 |
|
% Change |
|||
Sales volume by end-use market: |
|
|
|
|
|
|
||||||
Non-residential B&C |
|
20.1 |
|
22.3 |
|
(9.9 |
)% |
|
18.4 |
|
9.2 |
% |
Residential B&C |
|
1.6 |
|
2.5 |
|
(36.0 |
)% |
|
2.0 |
|
(20.0 |
)% |
Automotive |
|
3.2 |
|
3.4 |
|
(5.9 |
)% |
|
3.3 |
|
(3.0 |
)% |
Specialty products |
|
8.9 |
|
9.4 |
|
(5.3 |
)% |
|
9.2 |
|
(3.3 |
)% |
Total |
|
33.8 |
|
37.6 |
|
(9.9 |
)% |
|
32.9 |
|
2.7 |
% |
First Quarter 2024 Results vs. First Quarter 2023 Results
Net sales (sales less freight) in the first quarter of 2024 decreased 14.4% versus the first quarter of 2023 primarily due to lower sales volume and the pass-through of lower metal costs. Sales volume in the first quarter of 2024 decreased 9.9% versus the first quarter of 2023 but increased 2.7% versus the fourth quarter 2023.
Net new orders, which remain low compared to pre-pandemic levels but are growing, increased 61% in the first quarter of 2024 versus the first quarter of 2023, marking the sixth consecutive quarterly increase in incoming orders. Since
Open orders at the end of the first quarter of 2024 were 15 million pounds (versus 14 million pounds at the end of the fourth quarter of 2023 and 27 million pounds at the end of the first quarter of 2023). This level is below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions (particularly starting in early 2021 with the re-opening of markets following the rollout of vaccines) that resulted in long lead times, driving a peak in open orders of approximately 100 million pounds during the first quarter of 2022.
The Company is participating as part of a coalition of members of the
EBITDA from ongoing operations in the first quarter of 2024 decreased
-
Lower volume (
$3.3 million ) offset by higher net pricing after the pass-through of metal cost changes ($2.0 million ), lower labor and employee-related costs ($0.6 million ), lower supply expense ($0.6 million ), lower utility expense ($0.4 million ), lower selling, general and administrative ("SG&A") expenses ($0.3 million ) and lower freight rates ($0.2 million ); and -
The timing of the flow-through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at higher prices in a quickly changing commodity pricing environment, resulted in a charge of
$1.2 million in the first quarter of 2024 versus a benefit of$1.7 million in the first quarter of 2023.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in the Company's Quarterly Report on Form 10-Q for the period ended
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||
(In thousands, except percentages) |
|
|
|||||||
2024 |
|
2023 |
|
||||||
Sales volume (lbs) |
|
10,036 |
|
|
|
7,368 |
|
|
36.2% |
Net sales |
$ |
24,735 |
|
|
$ |
20,182 |
|
|
22.6% |
Ongoing operations: |
|
|
|
|
|
||||
EBITDA |
$ |
6,904 |
|
|
$ |
1,849 |
|
|
273.4% |
Depreciation & amortization |
|
(1,329 |
) |
|
|
(1,643 |
) |
|
19.1% |
EBIT* |
$ |
5,575 |
|
|
$ |
206 |
|
|
NM** |
Capital expenditures |
$ |
394 |
|
|
$ |
716 |
|
|
|
* For a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP, see the EBITDA from ongoing operations by segment statements in the Financial Tables in this press release. **Not meaningful ("NM") |
First Quarter 2024 Results vs. First Quarter 2023 Results
Net sales in the first quarter of 2024 were 22.6% higher compared to the first quarter of 2023, with volume increases in both Surface Protection and overwrap films. Surface Protection sales volume in the first quarter of 2024 increased 43% versus the first quarter of 2023 and 30% versus the fourth quarter of 2023. Given recent volume improvements for Surface Protection and other market indicators, the Company believes that the consumer electronics market is now in recovery mode.
EBITDA from ongoing operations during the first quarter of 2024 was
EBITDA from ongoing operations in the first quarter of 2024 increased
-
A
$4.4 million increase from Surface Protection primarily due to higher contribution margin associated with higher volume ($1.0 million ), favorable pricing ($0.3 million ), operating efficiencies and manufacturing costs savings ($1.9 million ), lower fixed costs ($0.4 million ), and lower SG&A ($0.7 million , including$0.6 million associated with the closure of theRichmond Technical Center in 2023). -
A
$0.7 million increase from overwrap films primarily due to cost improvements.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in the First Quarter Form 10-Q for additional information on resin price trends.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
||||||
(In thousands, except percentages) |
|
|
|||||||
2024 |
|
2023 |
|
||||||
Sales volume (lbs) |
|
21,973 |
|
|
|
19,845 |
|
|
10.7% |
Net sales |
$ |
30,113 |
|
|
$ |
31,527 |
|
|
(4.5)% |
Ongoing operations: |
|
|
|
|
|
||||
EBITDA |
$ |
1,963 |
|
|
$ |
1,350 |
|
|
45.4% |
Depreciation & amortization |
|
(751 |
) |
|
|
(700 |
) |
|
(7.3)% |
EBIT* |
$ |
1,212 |
|
|
$ |
650 |
|
|
86.5% |
Capital expenditures |
$ |
518 |
|
|
$ |
605 |
|
|
|
* For a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP, see the EBITDA from ongoing operations by segment statements in the Financial Tables in this press release. |
First Quarter 2024 Results vs. First Quarter 2023 Results
Net sales in the first quarter of 2024 decreased 4.5% compared to the first quarter of 2023 primarily due to lower selling prices that the Company believes are driven by excess global capacity and strong competition in
EBITDA from ongoing operations in the first quarter of 2024 increased
-
Lower raw material costs (
$1.9 million ), lower fixed costs ($1.7 million ), higher sales volume ($ 1.0 million ) and lower SG&A ($0.2 million ), partially offset by lower selling prices from global excess capacity and margin pressures ($2.1 million ) and higher variable costs ($1.3 million ); -
Foreign currency transaction gains (
$0.1 million ) in the first quarter of 2024 compared to foreign currency transaction losses ($0.1 million ) in the first quarter of 2023; and -
Net unfavorable foreign currency translation of Real-denominated operating costs (
$0.9 million ).
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in the First Quarter Form 10-Q for additional information on polyester fiber and component price trends.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
Corporate Expenses, Interest & Taxes
Corporate expenses, net in the first three months of 2024 decreased
Interest expense of
The effective tax rate was 16.7% in the first three months of 2024 compared to (48.8)% in the first three months of 2023. The change in effective tax rate was primarily due to pre-tax income in the first quarter of 2024 versus a pre-tax loss in the first three months of 2023. The effective tax rate for the first three months of 2024 varies from the 21% statutory rate primarily due to foreign rate differences and non-deductible expenses offset by Brazilian tax incentives and federal tax credits. The effective tax rate from ongoing operations comparable to the earnings reconciliation table provided in Note (a) to the Financial Tables in this press release was 19.0% for the first three months of 2024 versus 34.2% for the first three months of 2023 (see also Note (e) to the Financial Tables). Refer to Note 8 to the Company's Condensed Consolidated Financial Statements in the First Quarter Form 10-Q for an explanation of differences between the effective tax rate for income (loss) and the
Status of Agreement to Sell Terphane
On
As of
Total Debt, Financial Leverage and Debt Covenants
Total debt was
The Company has been focused on stringent management of net working capital, capital expenditures and costs during the current slowdown in business. Total debt increased
As of
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ materially from expectations include, without limitation, the following:
- inability to successfully complete strategic dispositions, including the Contingent Terphane Sale, failure to realize the expected benefits of such dispositions and assumption of unanticipated risks in such dispositions;
- inability to successfully transition into an asset-based revolving lending facility;
- noncompliance with any of the financial and other restrictive covenants in the Company's asset-based credit facility;
- the impact of macroeconomic factors, such as inflation, interest rates, recession risks and other lagging effects of the COVID-19 pandemic
- an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;
- failure to continue to attract, develop and retain certain key officers or employees;
- disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ; - failure to prevent foreign companies from evading anti-dumping and countervailing duties;
- unanticipated problems or delays with the implementation of the enterprise resource planning and manufacturing executions systems, or security breaches and other disruptions to the Company's information technology infrastructure;
- loss or gain of sales to significant customers on which the Company’s business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- failure of the Company’s customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our international operations; - political, economic and regulatory factors concerning the Company’s products;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
-
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging ; - an information technology system failure or breach;
- the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- impairment of the Surface Protection reporting unit's goodwill;
and the other factors discussed in the reports Tredegar files with or furnishes to the
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material Company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
|||||||
Condensed Consolidated Statements of Income (Loss) |
|||||||
(In Thousands, Except Per-Share Data) |
|||||||
(Unaudited) |
|||||||
|
|
|
|||||
|
|
Three Months Ended |
|||||
|
|
|
|||||
|
|
2024 |
|
2023 |
|||
Sales |
|
$ |
175,736 |
|
$ |
191,122 |
|
Other income (expense), net (c)(d) |
|
|
8 |
|
|
280 |
|
|
|
|
175,744 |
|
|
191,402 |
|
|
|
|
|
|
|||
Cost of goods sold (c) |
|
|
142,043 |
|
|
159,525 |
|
Freight |
|
|
6,666 |
|
|
6,043 |
|
Selling, R&D and general expenses (c) |
|
|
18,610 |
|
|
20,211 |
|
Amortization of intangibles |
|
|
464 |
|
|
503 |
|
Pension and postretirement benefits |
|
|
54 |
|
|
3,418 |
|
Interest expense |
|
|
3,455 |
|
|
2,311 |
|
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
|
507 |
|
|
69 |
|
Total |
|
|
171,799 |
|
|
192,080 |
|
Income (loss) before income taxes |
|
|
3,945 |
|
|
(678 |
) |
Income tax expense (benefit) (c) |
|
|
657 |
|
|
331 |
|
Net income (loss) |
|
$ |
3,288 |
|
$ |
(1,009 |
) |
|
|
|
|
|
|||
Earnings (loss) per share: |
|
|
|
|
|||
Basic |
|
$ |
0.10 |
|
$ |
(0.03 |
) |
Diluted |
|
$ |
0.10 |
|
$ |
(0.03 |
) |
|
|
|
|
|
|||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|||
Basic |
|
|
34,323 |
|
|
33,895 |
|
Diluted |
|
|
34,323 |
|
|
33,895 |
|
|
|||||||
|
|||||||
(In Thousands) |
|||||||
(Unaudited) |
|||||||
|
|
||||||
|
Three Months Ended |
||||||
|
|
||||||
|
2024 |
|
2023 |
||||
|
|
|
|
||||
Aluminum Extrusions |
$ |
114,222 |
|
|
$ |
133,370 |
|
|
|
24,735 |
|
|
|
20,182 |
|
|
|
30,113 |
|
|
|
31,527 |
|
Total net sales |
|
169,070 |
|
|
|
185,079 |
|
Add back freight |
|
6,666 |
|
|
|
6,043 |
|
Sales as shown in the condensed consolidated statements of income |
$ |
175,736 |
|
|
$ |
191,122 |
|
EBITDA from Ongoing Operations (i) |
|
|
|
||||
Aluminum Extrusions: |
|
|
|
||||
Ongoing operations: |
|
|
|
||||
EBITDA (b) |
$ |
12,540 |
|
|
$ |
14,638 |
|
Depreciation & amortization |
|
(4,542 |
) |
|
|
(4,411 |
) |
EBIT (b) |
|
7,998 |
|
|
|
10,227 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(1,167 |
) |
|
|
(493 |
) |
|
|
|
|
||||
Ongoing operations: |
|
|
|
||||
EBITDA (b) |
|
6,904 |
|
|
|
1,849 |
|
Depreciation & amortization |
|
(1,329 |
) |
|
|
(1,643 |
) |
EBIT (b) |
|
5,575 |
|
|
|
206 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(504 |
) |
|
|
2 |
|
|
|
|
|
||||
Ongoing operations: |
|
|
|
||||
EBITDA (b) |
|
1,963 |
|
|
|
1,350 |
|
Depreciation & amortization |
|
(751 |
) |
|
|
(700 |
) |
EBIT (b) |
|
1,212 |
|
|
|
650 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
— |
|
|
|
(78 |
) |
Total |
|
13,114 |
|
|
|
10,514 |
|
Interest income |
|
22 |
|
|
|
44 |
|
Interest expense |
|
3,455 |
|
|
|
2,311 |
|
Gain on investment in kaleo, Inc. ("kaléo") (d) |
|
— |
|
|
|
262 |
|
Stock option-based compensation costs |
|
— |
|
|
|
231 |
|
Corporate expenses, net (c) |
|
5,736 |
|
|
|
8,956 |
|
Income (loss) before income taxes |
|
3,945 |
|
|
|
(678 |
) |
Income tax expense (benefit) |
|
657 |
|
|
|
331 |
|
Net income (loss) |
$ |
3,288 |
|
|
$ |
(1,009 |
) |
|
||||||
Condensed Consolidated Balance Sheets |
||||||
(In Thousands) |
||||||
(Unaudited) |
||||||
|
|
|
|
|
||
|
|
|
|
|
||
Assets |
|
|
|
|
||
Cash & cash equivalents |
|
$ |
3,493 |
|
$ |
9,660 |
Restricted cash |
|
|
1,299 |
|
|
3,795 |
Accounts & other receivables, net |
|
|
73,032 |
|
|
67,938 |
Income taxes recoverable |
|
|
793 |
|
|
1,182 |
Inventories |
|
|
86,822 |
|
|
82,037 |
Prepaid expenses & other |
|
|
9,438 |
|
|
12,065 |
Total current assets |
|
|
174,877 |
|
|
176,677 |
Net property, plant and equipment |
|
|
177,972 |
|
|
183,455 |
Right-of-use leased assets |
|
|
16,761 |
|
|
11,848 |
Identifiable intangible assets, net |
|
|
9,364 |
|
|
9,851 |
|
|
|
35,717 |
|
|
35,717 |
Deferred income taxes |
|
|
24,320 |
|
|
25,034 |
Other assets |
|
|
3,520 |
|
|
3,879 |
Total assets |
|
$ |
442,531 |
|
$ |
446,461 |
Liabilities and Shareholders’ Equity |
|
|
|
|
||
Accounts payable |
|
$ |
84,925 |
|
$ |
95,023 |
Accrued expenses |
|
|
23,083 |
|
|
24,442 |
Lease liability, short-term |
|
|
2,871 |
|
|
2,107 |
ABL revolving facility (matures on |
|
|
128,330 |
|
|
126,322 |
Income taxes payable |
|
|
225 |
|
|
1,210 |
Total current liabilities |
|
|
239,434 |
|
|
249,104 |
Lease liability, long-term |
|
|
15,318 |
|
|
10,942 |
Long-term debt |
|
|
20,000 |
|
|
20,000 |
Pension and other postretirement benefit obligations, net |
|
|
6,582 |
|
|
6,643 |
Other non-current liabilities |
|
|
4,382 |
|
|
4,119 |
Shareholders’ equity |
|
|
156,815 |
|
|
155,653 |
Total liabilities and shareholders’ equity |
|
$ |
442,531 |
|
$ |
446,461 |
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
||||||
|
|
Three Months Ended |
||||||
|
|
2024 |
|
2023 |
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
3,288 |
|
|
$ |
(1,009 |
) |
Adjustments for noncash items: |
|
|
|
|
||||
Depreciation |
|
|
6,252 |
|
|
|
6,340 |
|
Amortization of intangibles |
|
|
464 |
|
|
|
503 |
|
Reduction of right-of-use lease asset |
|
|
610 |
|
|
|
551 |
|
Deferred income taxes |
|
|
623 |
|
|
|
411 |
|
Accrued pension income and post-retirement benefits |
|
|
54 |
|
|
|
3,418 |
|
Stock-based compensation expense |
|
|
686 |
|
|
|
186 |
|
Gain on investment in kaléo |
|
|
— |
|
|
|
(262 |
) |
Changes in assets and liabilities: |
|
|
|
|
||||
Accounts and other receivables |
|
|
(5,337 |
) |
|
|
(4,320 |
) |
Inventories |
|
|
(5,481 |
) |
|
|
14,840 |
|
Income taxes recoverable/payable |
|
|
(580 |
) |
|
|
(1,156 |
) |
Prepaid expenses and other |
|
|
1,890 |
|
|
|
1,816 |
|
Accounts payable and accrued expenses |
|
|
(10,306 |
) |
|
|
(28,977 |
) |
Lease liability |
|
|
(689 |
) |
|
|
(558 |
) |
Pension and postretirement benefit plan contributions |
|
|
(158 |
) |
|
|
(154 |
) |
Other, net |
|
|
965 |
|
|
|
(737 |
) |
Net cash provided by (used in) operating activities |
|
|
(7,719 |
) |
|
|
(9,108 |
) |
Cash flows from investing activities: |
|
|
|
|
||||
Capital expenditures |
|
|
(2,461 |
) |
|
|
(9,025 |
) |
Proceeds on sale of investment in kaléo |
|
|
— |
|
|
|
262 |
|
Proceeds from the sale of assets |
|
|
83 |
|
|
|
— |
|
Net cash provided by (used in) investing activities |
|
|
(2,378 |
) |
|
|
(8,763 |
) |
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings |
|
|
179,248 |
|
|
|
37,250 |
|
Debt principal payments |
|
|
(177,240 |
) |
|
|
(19,250 |
) |
Dividends paid |
|
|
— |
|
|
|
(4,419 |
) |
Net cash provided by (used in) financing activities |
|
|
2,008 |
|
|
|
13,581 |
|
Effect of exchange rate changes on cash |
|
|
(574 |
) |
|
|
83 |
|
Increase (decrease) in cash, cash equivalents and restricted cash |
|
|
(8,663 |
) |
|
|
(4,207 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
13,455 |
|
|
|
19,232 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
4,792 |
|
|
$ |
15,025 |
|
Notes to the Financial Tables |
||
(Unaudited) |
||
(a) |
Tredegar’s presentation of net income (loss) and diluted earnings (loss) per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, net periodic benefit cost for the frozen defined benefit pension plan and other items (which includes gains and losses for an investment accounted for under the fair value method), which have been presented separately and removed from net income (loss) and diluted earnings (loss) per share as reported under GAAP. Net income (loss) and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three months ended |
|
|
Three Months Ended |
|||||
($ in millions, except per share data) |
|
2024 |
2023 |
||||
Net income (loss) as reported under GAAP1 |
|
$ |
3.3 |
|
$ |
(1.0 |
) |
After-tax effects of: |
|
|
|
|
|||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.4 |
|
|
0.1 |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|||
Gain associated with the investment in kaléo |
|
|
— |
|
|
(0.2 |
) |
Other |
|
|
1.9 |
|
|
1.0 |
|
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination2 |
|
|
— |
|
|
2.6 |
|
Net income (loss) from ongoing operations1 |
|
$ |
5.6 |
|
$ |
2.5 |
|
|
|
|
|
|
|||
Earnings (loss) per share as reported under GAAP (diluted) |
|
$ |
0.10 |
|
$ |
(0.03 |
) |
After-tax effects per diluted share of: |
|
|
|
|
|||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.01 |
|
|
— |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|||
Gain associated with the investment in kaléo |
|
|
— |
|
|
(0.01 |
) |
Other |
|
|
0.05 |
|
|
0.03 |
|
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination2 |
|
|
— |
|
|
0.08 |
|
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.16 |
|
$ |
0.07 |
|
1. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (e). 2. For more information, see Note (g). |
(b) |
EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key segment profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. The Company uses sales less freight ("net sales") as its measure of revenues from external customers. For more business segment information, see Note 9 to the Company's Condensed Consolidated Financial Statements in the First Quarter Form 10-Q. |
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. The Company believes that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
||
(c) | Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the three months ended |
|
Three Months Ended |
|||
($ in millions) |
Pre-Tax |
Net of Tax |
||
Aluminum Extrusions: |
|
|
||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
||
Consulting expenses for ERP/MES project1 |
$ |
0.6 |
$ |
0.4 |
Storm damage to the |
|
0.1 |
|
0.1 |
Legal fees associated with the Aluminum Extruders Trade Case1 |
|
0.2 |
|
0.2 |
Total for Aluminum Extrusions |
$ |
0.9 |
$ |
0.7 |
|
|
|
||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
||
|
$ |
0.2 |
$ |
0.1 |
|
|
0.3 |
|
0.3 |
Total for |
$ |
0.5 |
$ |
0.4 |
Corporate: |
|
|||
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
||
Professional fees associated with business development activities1 |
$ |
0.5 |
$ |
0.4 |
Professional fees associated with remediation activities related to internal control over financial reporting1 |
|
0.9 |
|
0.7 |
Professional fees associated with the transition to the ABL Facility1 |
|
0.2 |
|
0.1 |
Total for Corporate |
$ |
1.6 |
$ |
1.2 |
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. 2. For more information, refer to Note 1 to the Company's Condensed Consolidated Financial Statements in the First Quarter Form 10-Q. |
|
Three Months Ended |
|||||
($ in millions) |
Pre-Tax |
Net of Tax |
||||
Aluminum Extrusions: |
|
|
||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
||||
Storm damage to the |
$ |
0.6 |
|
$ |
0.4 |
|
Total for Aluminum Extrusions |
$ |
0.6 |
|
$ |
0.4 |
|
|
|
|
||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
||||
Other restructuring costs - severance |
$ |
0.1 |
|
$ |
0.1 |
|
Total for |
$ |
0.1 |
|
$ |
0.1 |
|
Corporate: |
|
|
||||
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
||||
Professional fees associated with business development activities1 |
$ |
0.3 |
|
$ |
0.3 |
|
Professional fees associated with remediation activities related to internal control over financial reporting1 |
|
0.5 |
|
|
0.4 |
|
Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 Special Dividend1 |
|
(0.1 |
) |
|
(0.1 |
) |
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination2 |
|
3.4 |
|
|
2.6 |
|
Total for Corporate |
$ |
4.1 |
|
$ |
3.2 |
|
|
(d) |
On |
|
(e) | Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, net periodic benefit cost for the frozen defined benefit pension plan and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. It excludes items that we believe do not relate to Tredegar’s ongoing operations. | |
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three months ended |
($ in millions) |
Pre-tax |
|
Tax Expense (Benefit) |
|
After-Tax |
|
Effective Tax Rate |
||||||
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
||||||
Net income (loss) reported under GAAP |
$ |
3.9 |
|
|
$ |
0.6 |
|
$ |
3.3 |
|
|
16.7 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.5 |
|
|
|
0.1 |
|
|
0.4 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
2.5 |
|
|
|
0.6 |
|
|
1.9 |
|
|
|
|
Net income (loss) from ongoing operations |
$ |
6.9 |
|
|
$ |
1.3 |
|
$ |
5.6 |
|
|
19.0 |
% |
Three Months Ended |
|
|
|
|
|
|
|
||||||
Net income (loss) reported under GAAP |
$ |
(0.7 |
) |
|
$ |
0.3 |
|
$ |
(1.0 |
) |
|
(48.8 |
)% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.1 |
|
|
|
— |
|
|
0.1 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
1.0 |
|
|
|
0.2 |
|
|
0.8 |
|
|
|
|
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination |
|
3.4 |
|
|
|
0.8 |
|
|
2.6 |
|
|
|
|
Net income (loss) from ongoing operations |
$ |
3.8 |
|
|
$ |
1.3 |
|
$ |
2.5 |
|
|
34.2 |
% |
(f) Net debt is calculated as follows: |
|
|
|
|
|
||
($ in millions) |
|
2024 |
|
2023 |
||
ABL revolving facility (matures on |
|
$ |
128.3 |
|
$ |
126.3 |
Long-term debt |
|
|
20.0 |
|
|
20.0 |
Total debt |
|
|
148.3 |
|
|
146.3 |
Less: Cash and cash equivalents |
|
|
3.5 |
|
|
9.7 |
Less: Restricted cash |
|
|
1.3 |
|
|
3.8 |
Net debt |
|
$ |
143.5 |
|
$ |
132.8 |
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes. |
||
(g) | Beginning in 2022, and consistent with no expected required minimum cash contributions, no pension expense has been included in calculating earnings before interest, taxes, depreciation and amortization as defined in the Second Amended and Restated Credit Agreement, which is used to compute certain borrowing ratios and to compute non-GAAP net income (loss) from ongoing operations. | |
(h) | The ABL Facility has customary representations and warranties including, as a condition to each borrowing, that all such representations and warranties are true and correct in all material respects (including a representation that no Material Adverse Effect (as defined in the ABL Facility) has occurred since |
|
In accordance with the ABL Facility, the lenders have been provided with the Company’s financial statements, covenant compliance certificates and projections to facilitate their ongoing assessment of the Company. Accordingly, the Company believes the likelihood that lenders would exercise the subjective acceleration clause whereby prohibiting future borrowings is remote. As of |
||
(i) | Tredegar’s presentation of Consolidated EBITDA from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, net periodic benefit cost for the frozen defined benefit pension plan and other items (which includes gains and losses for an investment accounted for under the fair value method). Consolidated EBITDA from ongoing operations also excludes depreciation & amortization, stock option-based compensation costs, interest and income taxes. Consolidated EBITDA is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) or earnings (loss) per share as defined by GAAP. It excludes items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation of Consolidated EBITDA from ongoing operations for the three months ended |
|
Three Months Ended |
|||||
($ in millions) |
2024 |
2023 |
||||
Net income (loss) as reported under GAAP1 |
$ |
3.3 |
|
$ |
(1.0 |
) |
After-tax effects of: |
|
|
|
|||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.4 |
|
|
0.1 |
|
Gain associated with the investment in kaléo |
|
— |
|
|
(0.2 |
) |
(Gains) losses from sale of assets and other |
|
1.9 |
|
|
1.0 |
|
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination2 |
|
— |
|
|
2.6 |
|
Net income (loss) from ongoing operations1 |
|
5.6 |
|
|
2.5 |
|
Depreciation and amortization |
|
6.7 |
|
|
6.8 |
|
Stock option-based compensation costs |
|
— |
|
|
0.2 |
|
Interest expense |
|
3.5 |
|
|
2.3 |
|
Income taxes from ongoing operations1 |
|
1.3 |
|
|
1.3 |
|
Consolidated EBITDA from ongoing operations |
$ |
17.1 |
|
$ |
13.1 |
|
1. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (e). 2. For more information, see Note (g). |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240509797818/en/
neill.bellamy@tredegar.com
Source: